PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 69 filers reported holding PDS BIOTECHNOLOGY CORP in Q1 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,563 | +213.7% | 6,250 | +212.5% | 0.00% | – |
| Q2 2023 | $10,061 | -34.6% | 2,000 | -20.0% | 0.00% | – |
| Q1 2023 | $15,376 | +18.3% | 2,500 | +149.5% | 0.00% | – |
| Q4 2022 | $13,000 | +333.3% | 1,002 | +0.2% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 1,000 | -1.1% | 0.00% | – |
| Q2 2022 | $4,000 | -42.9% | 1,011 | -10.6% | 0.00% | – |
| Q1 2022 | $7,000 | -36.4% | 1,131 | -18.1% | 0.00% | – |
| Q4 2021 | $11,000 | -56.0% | 1,381 | -15.3% | 0.00% | – |
| Q3 2021 | $25,000 | -21.9% | 1,631 | -35.0% | 0.00% | – |
| Q2 2021 | $32,000 | +357.1% | 2,511 | +66.2% | 0.00% | – |
| Q1 2021 | $7,000 | +250.0% | 1,511 | +86.3% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 811 | 0.0% | 0.00% | – |
| Q3 2020 | $2,000 | – | 811 | +7272.7% | 0.00% | – |
| Q2 2020 | $0 | – | 11 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 11 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 117,242 | $428,000 | 0.28% |
| INSPIRION WEALTH ADVISORS, LLC | 313,669 | $1,145,000 | 0.25% |
| ACT CAPITAL MANAGEMENT, LLC | 12,000 | $44,000 | 0.06% |
| Sofinnova Investments, Inc. | 142,635 | $521,000 | 0.04% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 44,362 | $162,000 | 0.03% |
| XTX Topco Ltd | 21,085 | $77,000 | 0.03% |
| Andesa Financial Management Inc. | 12,500 | $46,000 | 0.03% |
| Virtu Financial LLC | 47,326 | $173,000 | 0.02% |
| Minot Wealth Management LLC | 10,000 | $37,000 | 0.01% |
| HAP Trading, LLC | 25,500 | $160,000 | 0.01% |